Last reviewed · How we verify
HBI 0201-ESO TCRT — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
HBI 0201-ESO TCRT (HBI 0201-ESO TCRT) — Hadassah Medical Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HBI 0201-ESO TCRT TARGET | HBI 0201-ESO TCRT | Hadassah Medical Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HBI 0201-ESO TCRT CI watch — RSS
- HBI 0201-ESO TCRT CI watch — Atom
- HBI 0201-ESO TCRT CI watch — JSON
- HBI 0201-ESO TCRT alone — RSS
Cite this brief
Drug Landscape (2026). HBI 0201-ESO TCRT — Competitive Intelligence Brief. https://druglandscape.com/ci/hbi-0201-eso-tcrt. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab